A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer

A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer - A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006717

Enrollment

200

Registered

2011-11-15

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small-cell lung cancer(Excluding squamous call lung cancer)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received bevacizumab containing chemotherapy.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
Efficacy and safety(Time to Treatment Failure)	—

Secondary

Measure	Time frame
Individual side effect and efficacy,Response rate,Overall survival	—

Countries

Japan

Contacts

Public ContactKatsunori Kagohashi

Tsukuba Univercity Hospital Department of respiratory medicine

Outcome results